| URL | https://www.reuters.com/business/healthcare-pharma |
| Source | Reuters |
| Date Published | 04/25/2025 |
| Author Name | deena beasley |
| Company/Division name | Amgen |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 750 |
| Year reshoring announced: | 2025 |
| Capital investment ($): | 900 |
| State(s) reshored to: | OH |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | biotech drug pharmaceuticals |
| What non-domestic negative factors made offshoring less attractive? | Tariffs |
| What domestic positive factors made reshoring more attractive? | , increase US capacity |